Technology
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
Technology
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
Finance
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rare disease treatments.
Sports
Chris Deacon’s tireless efforts led to a $100 million settlement with Horizon Blue Cross Blue Shield, though her contributions remain overshadowed by political figures.
Finance
Soaring health insurance expenses are pushing small businesses to abandon employee health coverage, challenging America's employer-based system.
Technology
With rising expenses, small companies are increasingly unable to provide health insurance, impacting millions of American workers and their families.
Technology
The current Ebola outbreak in the DRC faces severe obstacles to containment, risking a permanent endemic situation that could have global repercussions.
Finance
Medicare plans to reduce payments for 340B drugs by over 33%, a move criticized for potentially harming safety-net hospitals while benefiting for-profits.
Technology
Elevance Health has initiated legal action against the U.S. government, claiming improper recalculation of its Medicare Advantage ratings that jeopardize $115 million in funding.
Technology
Roche's new KRAS-targeted therapy is poised to redefine lung cancer treatment, showing impressive efficacy and safety in clinical trials.
Technology
A recent court ruling benefits Amgen, blocking a price cap on Enbrel, while Medicare expands access to obesity medications for older Americans.
Technology
Frequent and severe heat waves are significantly impacting public health, with rising temperatures posing increased risks to Americans' wellbeing.
Technology
The biotech sector has experienced a remarkable rise in performance, with major indices celebrating significant gains as the year progresses.
Technology
After a distressing buyout, Bluebird Bio's transformation into Genetix positions it to lead the market in sickle cell gene therapies by 2030.
Technology
UpDoc's FDA-cleared app integrates large language models to assist diabetes management, sparking conversations about AI's role in patient care.